Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm".

Publication/Presentation Date

1-1-2014

Volume

30

Issue

1

First Page

76

Last Page

77

ISSN

1537-2677

Disciplines

Medicine and Health Sciences

PubMedID

24398499

Department(s)

Department of Medicine

Document Type

Article

Share

COinS